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T-cell receptor γ alternate reading frame protein (TARP) is 
expressed by human prostate epithelial, prostate cancer, and 
mammary cancer cells, but is not found in normal mammary 
tissue. To date, this protein has only been described in 
humans. Additionally, no animal model has been established 
to investigate the potential merits of TARP as tumor marker 
or a target for adoptive tumor immunotherapy. In this study 
conducted to characterize feline T-cell receptor γ sequences, 
constructs very similar to human TARP transcripts were 
obtained by RACE from the spleen and prostate gland of cats. 
Transcription of TARP in normal, hyperplastic, and 
neoplastic feline mammary tissues was evaluated by 
conventional RT-PCR. In felines similarly to the situation 
reported in humans, a C-region encoding two open reading 
frames is spliced to a J-region gene. In contrast to humans, the 
feline J-region gene was found to be a pseudogene containing 
a deletion within its recombination signal sequence. Our 
findings demonstrated that the feline TARP ortholog is 
transcribed in the prostate gland and mammary tumors but 
not normal mammary tissues as is the case with human TARP.
Keywords: cat, C-region, J-region, T-cell receptor γ alternate 
reading frame protein (TARP), tumor marker
Introduction
　The T-cell receptor γ alternate reading frame protein 
(TARP) is transcribed and expressed by epithelial cells of 
the prostate gland as well as benign prostate gland tumors, 
prostate cancer cells, and breast cancer cells in humans 
[8,9,30]. The transcript is derived from the T-cell receptor 
γ (TRG) J-region gene, TRGJP in germline configuration, 
and the constant region gene, TRGC1, of the human TRG 
locus. This region contains two open reading frames 
(ORFs) [8] but only the first is translated. The product is a 
7-kDa protein with five leucine residues in heptad repeats 
followed by a basic region forming a potential leucine 
zipper motif [30]. The protein is located in the outer 
mitochondrial membrane, and its expression is increased 
in prostate and breast cancer cells [9,14,30]. Its expression 
in cancer cells in vitro leads to increased cell growth [29]. 
　Because of TARP expression in prostate and breast cancer, 
this protein has been tested as a target for cytotoxic T-cells 
[1,7,19] and helper T-cells [12] as an innovative approach 
for specific adoptive tumor immunotherapy. Similar 
truncated transcripts originating from T-cell receptor α 
genes have been found in human and murine sarcomas. 
These proteins also seem to be involved in regulating tumor 
cell proliferation [6]. The TARP promoter has also been 
used to study adoptive tumor therapy [2-4].
　TARP is transcribed from a J-region sequence and 
C-region sequence in germline configuration. In contrast, 
normal T-cell receptors are transcribed and translated from 
somatically rearranged genes of the same locus. This 
rearrangement of antigen receptor genes is known as 
V(D)J recombination [18]. Germline transcription of 
V-region and J-C-region genes takes place during V(D)J 
recombination within the thymus and their transcripts 
participate in the regulation of this process [13].
　V(D)J recombination is initiated by products of the 
recombination activating genes 1 and 2 that bind to the 
recombination signal sequence (RSS) and induce DNA 
double-strand breaks [15,24]. The signal ends and coding 
ends then undergo non-homologous end joining [10]. The 
RSSs are composed of a highly conserved heptamere, a 
conserved adenine rich nonamere, and a less conserved 
spacer region of 12 ± 1 or 23 ± 1 bp. The length of the 
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Table 1. Animals included in the present study





































Partially solid and partially tubular mammary carcinoma
Hypertrophic cardiomyopathy
Blunt trauma






 f: female, m: male, yr: year, mo: month.
spacer is used to characterize the RSSs, which are 
annotated as 12RSS and 23RSS, respectively [10,22,23]. 
　In the present study, we identified a feline transcript similar 
to human TARP composed of a J-region sequence and 
C-region sequence. This transcript was originally obtained 
from a splenic cDNA library established to characterize 
feline TRG sequences. Additionally, transcription of this 
construct was found in feline mammary neoplasm, similar 
to humans.
Materials and Methods
Animals and nucleic acid extraction
　Total RNA was extracted from the spleens of three 
domestic shorthair cats of different ages and genders (see 
Table 1, cats Nos. 1∼3) and the prostate gland of five male 
cats (cats Nos. 5∼9) submitted for routine pathological 
evaluation to our departments. Prior to performing rapid 
amplification of cDNA ends (RACE), total RNA was 
extracted with a Purescript RNA Isolation Kit (Biozym 
Scientific, Germany). Genomic DNA was isolated from 
the same tissues using a Puregene DNA Isolation Kit 
(Biozym Scientific, Germany). For RT-PCR amplification 
of presumed feline TARP sequences from feline prostate 
glands, total RNA was extracted with a High Pure RNA 
Tissue Kit (F. Hoffmann-La Roche, Germany).
Nucleic acid extraction from formalin-fixed and 
paraffin-embedded (FFPE) tissues
　To assess TARP transcription in feline mammary tumors, 
32 FFPE neoplastic and 14 normal or hyperplastic 
mammary tissue samples from 22 female animals submitted 
for routine diagnostics procedures in 2008 and 2009 were 
analyzed. Samples of all major tissues from three additional 
animals excluding the spleen were pooled to evaluate 
transcription in other tissues. Total RNA was extracted from 
30 to 40 paraffin sections of 2 μm thickness each. This was 
approximately equal to 10 mg of deparaffinized tissue. 
Tissue sections were deparaffinized by incubating with 800 
μL xylene for 5 min at room temperature and pelleting at 
14,000 × g at room temperature for 5 min. The resulting 
pellets were resuspended 300 μL of 99% ethanol and 
washed twice with 300 μL of 99% ethanol. Proteins were 
digested by resuspending the pellets in 300 μL cell lysis 
solution (Gentra Puregene Tissue Kit; Qiagen, Germany) 
and homogenizing by pipetting up and down. Next, 1.5 μL 
proteinase K solution (Gentra Puregene Tissue Kit; Qiagen, 
Germany) was added and the solution was incubated at 55oC 
for 1 to 3 h. The samples were then inactivated by incubating 
at 94oC for 10 min.
　After cooling to room temperature, 800 μL TRIzol 
Reagent (Invitrogen, USA) were added and the samples 
were incubated at room temperature for 5 min. Next, 200 
μL of chloroform (Carl Roth, Germany) were added. The 
samples were then incubated at room temperature for 5 min 
and centrifuged at 14,000 × g for 5 min at 4oC.
　To remove residual phenol from the samples, an 
additional 400 μL of chloroform were added to the upper 
phase. After phase separation, 600 μL of isopropanol (Carl 
Roth, Germany) were added to the upper phase and 
samples were pelleted at 14,000 × g and 4oC for 5 min. The 
pellets washed twice with 500 μL of 75% ethanol (Carl 
Roth, Germany), air dried, and resuspended in 20 μL 
diethylpyrocarbonate-treated water (Carl Roth, Germany).
5´RACE for feline TRG
　5´RACE was performed using a 5´/3´ RACE Kit (F. 
Hoffmann-La Roche, Germany) and a Multicycler PTC 200 
Gradient (Biozym, Germany). Amplification was carried out 
by nested PCR using Phusion High-Fidelity DNA 
Polymerase (BioCat, Germany) to ensure high sequence 
accuracy. The total reaction volume was 50 μL containing 1.5 
mM MgCl2, 0.2 mM of each dNTP (Invitrogen, USA), 0.2 
μM of each primer, 0.02 U/μL polymerase and 1 μg RNA. 
Primers were designed according to previously published 
sequences (D89023) [5]. FeTcRGr3 was used as a primer for 
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Table 2. Primer sequences and positions
No. Name Sequence (5´–3´) Orientation Position






















































*Position within D89023. †Position within feline T-cell receptor γ constant region gene (fTRGC). ‡bp upstream of the C-region in the spliced 
form (cDNA). §bp downstream of feline TRG J-region gene (fTRGJP). ∥presented in Cho et al. [5]. 
Fig. 1. Portion of the feline T-cell receptor γ (fTRG) locus 
containing the hypothetical feline T-cell receptor γ alternate 
reading frame protein (fTARP) and TARP mRNA (not to scale). 
Alternatively, two loci may exist: one containing fTRGC4 and the
carnivore-specific short interspersed nuclear elements 
(CAN-SINE), and a second one containing fTARP and fTRGJP. 
Arrows and numbers indicate primer position and orientation. 1:
FeTcRGr2, 2: FeTcRGr3/fTARPr2, 3: FTGR4, 4: FTGVf1/ 
fTARPf1, 5: fTARPf2, 6: FTGJr1, 7: FTGCr1/fTARPr1, 
fTARPr3, 8: FTGPIr1, C.-S.: CAN-SINE, 5´UTR: 5´untranslated
region, 3´UTR: 3´untranslated region, AAAAA: poly-A-tail.
cDNA synthesis, and FTGR4 along with FeTcRGr2 were 
used for amplification (for primer sequences, see Table 2). 
Primer annealing locations and the location of cloned 
sequences are shown in Fig. 1. DNA was denatured for 30 sec 
at 98oC, each cycle consisted of melting for 10 sec at 98oC, 
annealing for 30 sec, and elongation for 30 sec at 72oC (for 
reaction conditions see Table 3). This was followed by a final 
elongation for 5 min at 72oC. PCR products were cloned with 
the AccepTor Vector Kit (Merck, Germany) and sequenced 
by a commercial laboratory (Eurofins MWG Operon, 
Germany) as previously described [26].
3´RACE of feline TARP sequences
　3´RACE was performed using a 5´/3´ RACE Kit (F. 
Hoffmann-La Roche, Germany) a Multicycler PTC 200 
Gradient (Biozym, Germany). Amplification was 
catalyzed by Phusion High-Fidelity DNA Polymerase 
(BioCat, Germany) and performed in two steps. First, 
second-strand synthesis was conducted using the first half 
of a 50-μL PCR master mix composed as listed above 
containing 0.1 μM fTARPf1 as the gene-specific primer. 
After ten PCR cycles, the other half of the aforementioned 
master mix was added along with 0.24 μM of the second 
gene-specific primer fTARPf2 and 0.16 μM of the RACE 
anchor primer. Reaction conditions are listed in Table 3. 
The PCR products were cloned and sequenced as described 
above. 
RT-PCR and PCR amplification of feline TARP
　cDNA was synthesized using a RevertAid H Minus First 
Strand cDNA Synthesis Kit (Thermo Fisher Scientific, 
USA) using the included random hexamer primers as 
recommended by the manufacturer’s instructions. GoTaq 
DNA Polymerase (Promega, USA) was used to amplify 
cDNA and genomic DNA. The PCR reaction contained 100 
ng DNA, 2.0 mM MgCl2, 0.2 mM of each dNTP, 0.2 μM of 
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Table 3. Reaction conditions for RACE
5´RACE
FTRG4 FeTcRGr2
Temp‡ Cycles Temp‡ Cycles
55 35 60 35
3´RACE
Second strand synthesis Second half of mastermix Further amplification



























*Initial temperature followed by a touch down of −0.5oC per cycle. †Time in sec. ‡Temperature in oC. 
Table 4. Reaction conditions for RT-PCR and PCR
TARP TRG: FTGFr2f1/ FTGFR4r1 TRG: FTGFr2f1/ FTGFR4r2/3§





























































*Initial temperature followed by a touch down of −0.5oC per cycle. †Time in sec. ‡Temperature in oC. §Also used for FTGFR1f2 and FTGFR4r2.
each primer, and 0.025 U/μL DNA polymerase. The final 
reaction volume was 25 μL and the PCR conditions are 
listed in Table 4. fTARPf1 and -2 were used as forward 
primers; FTGJr1, fTARPr1, fTARPr2, and FTGPIr1 were 
used as reverse primers.
RT-PCR amplification of recombined TRG sequences
　Transcription of TRG sequences in feline prostate glands 
was examined using primers designed to amplify 
recombined feline TRG DNA [25,28]. A PCR master mix 
was prepared as described above and the reaction 
conditions are listed in Table 4.
Sequence analysis
　Sequences were analyzed using the Basic Local 
Alignment Search Tool (National Center for Biotechnology 
Information, USA) and ClustalW (UCD Dublin, Ireland). 
GeneDoc 2.6.003 (Pittsburgh Supercomputing Center, 
USA) was used for displaying multiple sequence 
alignments. The sequences generated have been submitted 
to the Nucleotide Sequence Database (European Molecular 
Biology Laboratory, Germany): AM502837∼AM502846, 
AM940997 (complete CDS), and FN433011.
RT-PCR amplification of TARP in feline mammary 
tumors
　Approximately 500 ng of total RNA from each sample 
were reverse transcribed using RevertAid H Minus First 
Strand cDNA Synthesis Kit (Thermo Fisher Scientific, 
USA). A PCR master mix of the same composition as 
described above was used. The fTARPf2 and fTARPr3 
primers were used and the reaction conditions were 
slightly modified. Starting temperature for annealing was 
63oC followed by a touch down of 1oC per cycle for 10 
cylcles. Afterwards 57oC were used. cDNA amplification 
was monitored using the YWHAZ housekeeping gene as 
previously described [20].
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Fig. 2. (A) Alignment of the deduced amino acid sequences of human and putative feline TARP. In human TARP (hTARP), five leucine
residues in heptad repeats can be found. In fTARP, only four leucine residues were observed. The basic region downstream of the last
leucine displayed high homology. (B) Alignment of clone pFTGII.164, the genomic sequence of fTRGJP (gnl|ti|755161287), and 
fTRGJ2.3 (gnl|ti|915242736). In fTRGJP, the heptamer of the 12RSS was deleted. The spacer of the fTRGJ2.3 12RSS was either 10-
or 11-bp long, or the nonamer ended on ‘T’. 
Results 
Characterization of feline TARP
　The seven clones (AM502839∼AM502845) produced 
by a classical 5´RACE procedure using total RNA 
extracted from the spleens of two different cats (Nos. 2 and 
3) included a transcript similar to human TARP (Fig. 2A). 
This transcript consisted of a TRG J-region sequence that 
was spliced to a C-region sequence (Fig. 1). To analyze the 
whole sequence of the transcript, 3´RACE was conducted 
with primers specific for the J-region sequence (cat No. 1). 
Resulting clones could only be sequenced in the forward 
direction. Sequencing with the reverse primer came to a halt 
within the poly-A-tail. Therefore, approximately 70 bp at 
the 3´ end have not been sequenced. However, the sequence 
was almost identical (over 99% homology) to fTRGC4 that 
has been sequenced previously (GenBank accession No. 
AM489512). fTARP was also cloned and sequenced from 
total splenic RNA of cat No. 1 using fTARPf1 and 
FeTcRGr3/fTARPr2 (primers Nos. 4 and 2 shown in Fig. 
1). This amplicon had more than 99% identity to the clones 
from animals Nos. 2 and 3. 
　To measure TARP transcription in the feline prostate 
gland, fTARP was amplified and sequenced from total 
prostatic RNA of five animals (Nos. 5 through 9; Fig. 3C) 
using the same primers. These amplicons also had more 
than a 99% identity to the sequenced clones. The C-region 
sequence encoded two ORFs. The first one started at the 
beginning of the C-region, contained 189 bp, and was out of 
frame compared to the fTRG transcripts. The second started 
at an ‘ATG’ site 185 bp downstream from the beginning of 
the C-region and contained 462 bp. This second ORF was in 
frame compared to the fTRG transcripts. 
　Sequence similarity of the coding sequence for human 
and feline TARP was 84% at the nucleotide level and 70% 
at the amino acid level (Fig. 2A). Sequence similarity of 
the second ORF between cats and humans was 
approximately 30% at the nucleotide level. The included 
J-region sequences had a 37% sequence similarity.
　All feline C-region genes except for TARP/TRGC4 
contained a start codon at the same position as human TARP. 
In TARP/TRGC4, a ‘TTG’ codon was found in this position. 
However, there was a start codon precisely at the beginning 
of the C-region. This position was located 12 bp upstream of 
the ‘TTG’ codon.
　Similarity of the J-region sequence was 76% to 
fTRGJ2.1, 83% to fTRGJ2.2, 88% to fTRGJ2.3, and 80% 
to fTRGJ2.4. The J-region sequence in fTARP had a 19-bp 
deletion at the position of the 12RSS (Fig. 2B). This 
J-region was therefore named fTRGJP. The sequence, 
including a 5´ intron, was also found in feline genomic 
sequences (gnl|ti|755161287) from the Trace Archive 
Nucleotide BLAST database (NCBI, USA). 
　To determine the genomic organization of feline TARP, 
the fTARPf1, FTGJr1, and fTARPr1 primers were 
designed. An amplicon recovered from genomic DNA 
using fTARPf1 and FTGJr1 was identified in all animals 
tested (Fig. 3A). The amplicon produced by fTARPr1, 
indicating the presence of spliced TARP DNA within the 
genome, was produced from the DNA of only one animal 
(No. 4; Fig. 3B). Additionally, the FTGPIr1 primer was 
specific for the intron downstream of fTRGJP. The 
amplicon produced by this primer was also recovered in all 
animals tested (Fig. 3A). 
　For cat No. 4, we amplified DNA pretreated with DNase 
and RNase using fTARPf1 and fTARPr1 or FTGPIr1. No 
product was generated from the DNase-treated DNA, 
indicating that both variants are present in genomic DNA 
(Fig. 3B). The amplicons generated by fTARPf1 and 
fTARPr1 or FTGPIr1 were cloned and sequenced. Similarity 
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Table 5. Transcription of TARP in feline mammary tissues (n = 14), mammary neoplasms (n = 32), and lymph nodes (n = 5)
Diagnosis
Number of cases
Positive  cases (%)


















































Density of bands; −: negative result, (+): weak, +: moderate, ++: strong. NA: not applicable. 
Fig. 3. PCR amplification of feline TARP with different primer sets from genomic DNA and cDNA. (A) TARP amplification of genomic
DNA from five different cats using FTGVf1/fTARPf1 as the forward primer and FTGJr1 (lanes 1, 11, 21, 31, and 41 are specific for 
fTRGJP), FTGCr1/fTARPr1 (lanes 2, 12, 22, 32, and 42 are specific for spliced TARP) and FTGPIr1 (lanes 3, 13, 23, 33, and 43 specific
for the intron downstream of fTRGJP) as the reverse primers. Lane 0: control (no template), lane M: DNA size marker. (B) 
Amplification of DNA from cat No. 4 using FTGVf1/fTARPf1 and FTGCr1/fTARPr1 (lanes 1∼4 are specific for spliced TARP) or 
FTGPIr1 (lanes 11∼14 are specific for the intron downstream of fTRGJP). DNA was untreated (lanes 1 and 11), treated with RNase
(lanes 2, 3, 12 and 13), and treated with DNase (lanes 4 and 14). Lane 0: control (no template), lane M: DNA size marker. (C) 
Amplification of TARP cDNA/mRNA from feline prostate glands (primers: fTARPf1 and fTARPr2). Lane 1: cat No. 5, lane 2: cat No.
6, lane 3: cat No. 7, lane 4: cat No. 8, lane 5: cat No. 9, lane 0: control (no template). (D) Amplification of TARP cDNA/mRNA with
fTARPf2 and fTARPr3 primers from normal mammary gland (lanes 1, 2, and 5), mammary glandular hyperplasia (lane 3), mammary
adenomas (lanes 14 and 15), mammary adenocarcinomas (lanes 4, 6, 7, 9, 10, 11, and 12), normal lymph node (lane 13), and lymph node
metastases of mammary adenocarcinoma (lane 8). Lane M: DNA size marker, lane 0: control (no template), lane +: positive control.
to fTARP was approximately 99% for both the genomic and 
cDNA sequences. Weak transcription of recombined 
TRG-V domains was detected within the prostate of cats 
Nos. 5∼9 with the primers fTRGFR2f1 and fTRGFR4r1 
(data not shown). Additional primer combinations yielded 
no amplicons.
Transcription of TAPR in feline mammary tumors
　The amount of total RNA extracted from FFPE mammary 
tissues ranged from 0.6 to 46 μg (average: 8.6 μg, median: 
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5 μg, average 260/280 ratio: 1.6). Results of RT-PCR 
amplification of feline TARP sequences are summarized in 
Table 5. Because band density varied considerably, the 
results are presented in a semi-quantitative manner (Fig. 
3D). The majority (81%) of the neoplastic tissues 
expressed TARP sequences whereas this expression was 
not observed in any of the normal mammary gland 
samples. No TARP mRNA was detected in the pooled 
RNA samples from other tissues of the three cats tested. All 
samples yielded bands for YWHAZ of approximately 
equal density.
Discussion
　Transcription of a J-region sequence spliced to a C-region 
sequence is typical for human TARP. We detected the same 
constellation for one feline C-region and J-region 
sequence, suggesting that this transcript is the feline 
counterpart of human TARP. Whether these genes are 
located within the feline TRG locus, as is the case of human 
TARP [8,30], or comprise a separate locus that arose by 
gene duplication is not certain at the moment. Interestingly, 
the C-region sequence involved (fTRGC4) was never 
detected in combination with a functionally recombined 
variable domain [26-28]. Thus, we could not demonstrate 
its utilization as an fTRGC region. Furthermore, this 
C-region was associated with a carnivore-specific short 
interspersed element (CAN-SINE) located 468 bp in the 3´ 
direction [27]. 
　Due to its homology with rabbit TRG cDNA sequences 
(D38136, 86% nucleic acid identity), we first speculated 
that the presumed TARP we amplified could be a 
recombined VJ sequence. However, the sequence specific 
for the fTARPf1 primer is located within the intron 
upstream of TRGJP. An amplicon can thus be produced 
from genomic DNA using this primer and FTGJr1.
　Interestingly, the start codon in this sequence was found 
12 bp upstream from the corresponding position in human 
TARP. This indicates that after mutation of the original start 
codon present in all other feline C-region genes, a second 
mutation must have occurred. Therefore, fTRGC4 might 
have another role than that specific for a C-region of TRG.
　The associated J-region sequence in fTARP features a 
19-bp deletion within its RSS. fTRGJP is thus a 
pseudogene with regard to the TRG locus since productive 
recombination with a V-region is prevented. TR and 
immunoglobulin loci of all species tested so far contain 
multiple pseudogenes [10,13]. Pseudogenes arise from 
point mutations, deletions, or insertions after the regions 
have been duplicated. A pseudogene results if these 
mutations either alter the RSS or cause a reading frame 
shift [17,21]. 
　Another possible manner in which the presumed fTARP 
transcript was formed, at least within splenic tissue, could be 
transcription of this sequence in a germline configuration. 
Each gene that encodes a region of the antigen receptors has 
its own promoter that is probably necessary for successful 
recombination [11]. These promoters induce transcription 
prior to recombination [10]. V-region and J-C-region genes 
are transcribed in germline configuration during 
recombination, but this takes place within the thymus in 
pre-T-cells and is induced by IL-7 signaling [13]. It is 
therefore unlikely that the alleged TARP transcript in spleen 
and prostate gland is caused by germline transcription. 
However, transcription of J-region genes in germline 
configuration has been observed in the spleen of fetal and 
adult cattle, but it has not been determined whether these 
transcripts could resemble TARP [16]. Excluding fTRGJP, 
we did not detect any transcription of fTRG sequences in 
germline configuration in feline spleen tissue. With regard to 
fTARP, this J-region sequence is only part of the 5’ 
untranslated region.
　Additionally, fTARP was amplified in cat No. 4 from 
genomic DNA in “spliced form”. This finding indicates 
that in some animals fTARP additionally exists as a 
processed and reintegrated pseudogene. The fact that we 
found this pseudo gene in only one of the animals studied 
indicates that this transcript was very recently reintegrated 
into the cat’s genome.
　Similar to humans, alleged feline TARP transcripts were 
present in feline mammary adenocarcinomas and adenomas 
in the current study. However, cases of glandular hyperplasia 
were also positive for TARP transcription. This has not been 
reported in humans. Further testing should be conducted to 
determine whether TARP transcription indicates potential 
progression towards neoplastic transformation. Additionally, 
weak transcription found in lymphatic tissues should be 
further investigated because this might hamper the use of 
fTARP in tumor immunotherapy.
　In summary, we have described an fTRC region highly 
transcribed in combination with an fTRGJ pseudogene in 
feline spleen and prostate as well as neoplastic tissues from 
feline mammary glands. The molecular characteristics 
were highly similar to those of human TARP. Further 
characterization of this transcript in cats could lead to a 
better understanding of its physiological function and 
significance. Additionally, if this mRNA sequence is also 
translated in feline cancer cells, it could serve as a tumor 
marker or a target for anti-cancer immunotherapy in this 
species. Furthermore, characterization of TARP in cats 
may result in a suitable animal model to analyze its 
potential as target for adoptive tumor immunotherapy. 
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